Egyszerű nézet

dc.contributor.author Fazekas, Levente
dc.contributor.author Sax, Balázs
dc.contributor.author Hartyánszky, István
dc.contributor.author Pólos, Miklós
dc.contributor.author Horkay, Ferenc
dc.contributor.author Varga T
dc.contributor.author Rácz, Kristóf
dc.contributor.author Németh, Endre
dc.contributor.author Székely, Andrea
dc.contributor.author Paulovich, Erzsébet
dc.contributor.author Heltai, Krisztina
dc.contributor.author Zima, Endre István
dc.contributor.author Szabolcs, Zoltán
dc.contributor.author Merkely, Béla Péter
dc.date.accessioned 2015-09-09T11:09:52Z
dc.date.available 2015-09-09T11:09:52Z
dc.date.issued 2015
dc.identifier.citation pagination=521-527; journalVolume=156; journalIssueNumber=13; journalTitle=ORVOSI HETILAP;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/1943
dc.identifier.uri doi:10.1556/OH.2015.30115
dc.description.abstract INTRODUCTION: Since the celebration of the 20th anniversary of the first heart transplantation in Hungary in 2012 the emerging need for modern heart failure management via mechanical circulatory support has evolved. In May 2012 the opening of a new heart failure and transplant unit with 9 beds together with the procurement of necessary devices at Semmelweis University accomplished this need. AIM: The aim of the authors was to report their initial experience obtained in this new cardiac assist device program. METHOD: Since May, 2012, mechanical circulatory support system was applied in 89 cases in 72 patients. Indication for support were end stage heart failure refractory to medical treatment and acute left or right heart failure. RESULTS: Treatment was initiated for acute graft failure after heart transplantation in 27 cases, for end stage heart failure in 24 cases, for acute myocardial infarction in 21 cases, for acute postcardiotomy heart failure in 14 cases, for severe respiratory insufficiency in 2 cases and for drug intoxication in one case. Among the 30 survivor of the whole program 13 patients were successfully transplanted. CONCLUSIONS: The available devices can cover all modalities of current bridge therapy from short term support through medium support to heart transplantation or long term support and destination therapy. These conditions made possible the successful start of a new cardiac assist device program. Orv. Hetil., 2015, 156(13), 521-527.
dc.relation.ispartof urn:issn:0030-6002
dc.title A mechanikus keringéstámogatás életet ment - a műszívprogram első három évének tapasztalata a Semmelweis Egyetemen
dc.type Journal Article
dc.date.updated 2015-07-04T13:28:20Z
dc.language.rfc3066 hu
dc.identifier.mtmt 2870511
dc.identifier.wos 000351390800004
dc.identifier.pubmed 25796280
dc.contributor.department SE/AOK/K/Aneszteziológiai és Intenzív Terápiás Klinika
dc.contributor.department SE/AOK/K/Városmajori Szív- és Érgyógyászati Klinika
dc.contributor.institution Semmelweis Egyetem


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet